Get the latest public health information from CDC: https://www.coronavirus.gov
Get the latest research information from NIH: https://www.covid19.nih.gov/
NIH staff guidance on coronavirus (NIH Only): https://employees.nih.gov/pages/coronavirus/
- Home
- About NICHD
- Organization
- Division of Extramural Research (DER)
- Extramural Scientific Branches
- Fertility and Infertility Branch (FIB)
- Branch-Specific Funding Opportunities and Notices
FIB Funding Opportunities and Notices
NICHD publishes and participates in various Funding Opportunity Announcements (FOAs) and NIH Guide Notices (NOTs) to support research and training activities. The following table includes branch-specific FOAs, sorted by date from most recent to older. Select a table heading to change how the information is sorted.
A listing of NICHD-specific NOTs is available on the Active FOAs and NOTs page.
Please note: the following are sorted alphabetically by announcement number. Select a table heading to change how the information is sorted.
| Announcement Number | Submissions Date(s) | Expiration Date | Activity Code(s) | Title |
|---|---|---|---|---|
| PAR-20-281 | October 19, 2020, June 19, 2021, February 19, 2022, October 19, 2022, June 19, 2023 |
June 20, 2023 | R01 | Fertility Status as a Marker for Overall Health (R01 Clinical Trial Optional) |
| PAR-20-282 | October 19, 2020, June 19, 2021, February 19, 2022, October 19, 2022, June 19, 2023 | June 20, 2023 | R21 | Fertility Status as a Marker for Overall Health (R21 Clinical Trial Not Allowed) |
| RFA-HD-21-012 | July 1, 2020 | P50 | National Centers for Translational Research in Reproduction and Infertility (NCTRI) (P50 Clinical Trial Optional) | |
| RFA-HD-20-021 | November 26, 2019 | November 27, 2019 | R21 | Fertility and Fertility Preservation for Patients with Diseases that Previously Precluded Reproduction (R21 Clinical Trial Optional) |
| RFA-HD-20-010 | December 3, 2019 |
December 4, 2019 | R43/R44 | Technologies to Advance Precision Medicine Diagnosis and Treatment of Infertility, Reproductive Tract and Gynecologic Disorders Affecting Fertility (R43/R44 Clinical Trial Optional) |
| PA-18-838 | Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is October 5, 2018. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
September 8, 2021 | R01 | Role of Gut Microbiome in Regulating Reproduction and Its Impact on Fertility Status in Women Living with and Without HIV (R01 - Clinical Trial Optional) |
| PA-18-839 | Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is October 16, 2018. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
September 8, 2021 | R21 | Role of Gut Microbiome in Regulating Reproduction and Its Impact on Fertility Status in Women Living with and Without HIV (R21 Clinical Trial Optional) |
| PAR-18-830 | November 7, 2018, June 3, 2019, March 3, 2020, November 7, 2020, June 3, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
June 4, 2021 | R01 | The Role of Epitranscriptomics in Development and Disease (R01 - Clinical Trial Not Allowed) |
| PAR-18-831 | November 7, 2018, June 3, 2019, March 3, 2020, November 7, 2020, June 3, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
June 4, 2021 | R21 | The Role of Epitranscriptomics in Development and Disease (R21 - Clinical Trial Not Allowed) |
| PA-17-091 | Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is June 5, 2017. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
May 8, 2020 | R01 | Fertility Status as a Marker for Overall Health (R01) |
| PA-16-445 | Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. | January 8, 2020 | R01 | Trophoblast Differentiation and Function (R01) |
BACK TO TOP